KKR Eyes $10 B Sale of Flora Food Group, Former Unilever Spreads Unit

KKR
April 30, 2026

KKR is exploring a sale of Flora Food Group, the former Unilever spreads business that includes well‑known brands such as Flora and Country Crock. The private‑equity firm has set a target valuation of $10 billion for the unit, which it acquired in 2017 for €6.8 billion—approximately $8.0 billion at the time of purchase. The sale follows a 2024 attempt that was shelved after negotiations with Abu Dhabi’s sovereign‑wealth fund ADQ collapsed.

The decision to divest Flora Food Group reflects KKR’s broader strategic shift toward higher‑margin core private‑equity and insurance businesses. In recent months the spreads market has faced headwinds, with plant‑based spread sales falling 10% in 2025 as consumers return to traditional butter and high‑protein dairy products. The decline in growth for the unit has prompted KKR to consider unlocking capital that can be redeployed into its expanding insurance portfolio and other high‑margin private‑equity opportunities.

Flora Food Group’s financial performance has shown a slowdown in growth, with the 2025 plant‑based segment reporting a 10% drop in sales. While the unit still commands strong brand recognition, the shift in consumer preferences and the competitive pressure from dairy‑based spreads have eroded its growth trajectory, making a sale an attractive option for KKR to reallocate resources to more promising sectors.

The potential sale is expected to attract interest from other buyout firms and could trigger a competitive bidding process. A successful transaction would streamline KKR’s portfolio, reinforce its three‑pillar model of asset management, insurance, and strategic holdings, and provide the firm with additional capital to pursue new investments in its core high‑margin businesses.

The move also aligns with a broader consolidation trend in the food industry, as companies seek scale and efficiency in a market where consumer preferences are shifting and margins are tightening. KKR’s exploration of a $10 billion sale therefore signals a strategic realignment that could reshape its investment focus and capital allocation strategy.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.